Analysis of the potential effect of ponatinib on the QTc interval in patients with refractory hematological malignancies

Analysis of the potential effect of ponatinib on the QTc interval in patients with refractory hematological malignancies

Bibliographic Details
Main Authors: Sonnichsen, Daryl, Dorer, David J., Cortes, Jorge, Talpaz, Moshe, Deininger, Michael W., Shah, Neil P., Kantarjian, Hagop M., Bixby, Dale, Mauro, Michael J., Flinn, Ian W., Litwin, Jeffrey, Turner, Christopher D., Haluska, Frank G.
Format: Online
Language:English
Published: Springer-Verlag 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668123/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668123/

Similar Items